These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25127241)

  • 1. Integrating transcriptomics with metabolic modeling predicts biomarkers and drug targets for Alzheimer's disease.
    Stempler S; Yizhak K; Ruppin E
    PLoS One; 2014; 9(8):e105383. PubMed ID: 25127241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and central nervous system metabolic alterations in Alzheimer's disease.
    van der Velpen V; Teav T; Gallart-Ayala H; Mehl F; Konz I; Clark C; Oikonomidi A; Peyratout G; Henry H; Delorenzi M; Ivanisevic J; Popp J
    Alzheimers Res Ther; 2019 Nov; 11(1):93. PubMed ID: 31779690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Approaches to Assess Abnormal Metabolism in Alzheimer's Disease Using Transcriptomics.
    Lüleci HB; Uzuner D; Çakır T; Thambisetty M
    Methods Mol Biol; 2023; 2561():173-189. PubMed ID: 36399270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.
    Trushina E; Dutta T; Persson XM; Mielke MM; Petersen RC
    PLoS One; 2013; 8(5):e63644. PubMed ID: 23700429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated transcriptomics reveals the brain and blood biomarkers in Alzheimer's disease.
    Yu H; Wang F; Wu JJ; Gong J; Bi S; Mao Y; Jia D; Chai GS
    CNS Neurosci Ther; 2023 Dec; 29(12):3943-3951. PubMed ID: 37334737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathway-based integration of multi-omics data reveals lipidomics alterations validated in an Alzheimer's disease mouse model and risk loci carriers.
    Garcia-Segura ME; Durainayagam BR; Liggi S; Graça G; Jimenez B; Dehghan A; Tzoulaki I; Karaman I; Elliott P; Griffin JL
    J Neurochem; 2023 Jan; 164(1):57-76. PubMed ID: 36326588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in Sporadic and Familial Alzheimer's Disease.
    Lista S; O'Bryant SE; Blennow K; Dubois B; Hugon J; Zetterberg H; Hampel H
    J Alzheimers Dis; 2015; 47(2):291-317. PubMed ID: 26401553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrative metabolomics-genomics approach reveals key metabolic pathways and regulators of Alzheimer's disease.
    Horgusluoglu E; Neff R; Song WM; Wang M; Wang Q; Arnold M; Krumsiek J; Galindo-Prieto B; Ming C; Nho K; Kastenmüller G; Han X; Baillie R; Zeng Q; Andrews S; Cheng H; Hao K; Goate A; Bennett DA; Saykin AJ; Kaddurah-Daouk R; Zhang B; ;
    Alzheimers Dement; 2022 Jun; 18(6):1260-1278. PubMed ID: 34757660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing Alzheimer's disease through metabolomics and investigating anti-Alzheimer's disease effects of natural products.
    Yi L; Liu W; Wang Z; Ren D; Peng W
    Ann N Y Acad Sci; 2017 Jun; 1398(1):130-141. PubMed ID: 28632966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revealing the Molecular Mechanisms of Alzheimer's Disease Based on Network Analysis.
    Bayraktar A; Lam S; Altay O; Li X; Yuan M; Zhang C; Arif M; Turkez H; Uhlén M; Shoaie S; Mardinoglu A
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer's disease.
    Lin CX; Li HD; Deng C; Liu W; Erhardt S; Wu FX; Zhao XM; Guan Y; Wang J; Wang D; Hu B; Wang J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34953465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease.
    Hampel H; Bürger K; Teipel SJ; Bokde AL; Zetterberg H; Blennow K
    Alzheimers Dement; 2008 Jan; 4(1):38-48. PubMed ID: 18631949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UHPLC-QTOF/MS-based metabolomics investigation for the protective mechanism of Danshen in Alzheimer's disease cell model induced by Aβ
    Zhang M; Liu Y; Liu M; Liu B; Li N; Dong X; Hong Z; Chai Y
    Metabolomics; 2019 Jan; 15(2):13. PubMed ID: 30830431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics-based promising candidate biomarkers and pathways in Alzheimer's disease.
    Kang J; Lu J; Zhang X
    Pharmazie; 2015 May; 70(5):277-82. PubMed ID: 26062293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Network Analysis Reveals Altered Bile Acid Synthesis and Metabolism in Alzheimer's Disease.
    Baloni P; Funk CC; Yan J; Yurkovich JT; Kueider-Paisley A; Nho K; Heinken A; Jia W; Mahmoudiandehkordi S; Louie G; Saykin AJ; Arnold M; Kastenmüller G; Griffiths WJ; Thiele I; ; Kaddurah-Daouk R; Price ND
    Cell Rep Med; 2020 Nov; 1(8):100138. PubMed ID: 33294859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic Pathway Pairwise-Based Signature as a Potential Non-Invasive Diagnostic Marker in Alzheimer's Disease Patients.
    Feng Y; Chen X; Zhang XD; Huang C
    Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
    Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
    Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Matter Lipids as a Ketogenic Fuel Supply in Aging Female Brain: Implications for Alzheimer's Disease.
    Klosinski LP; Yao J; Yin F; Fonteh AN; Harrington MG; Christensen TA; Trushina E; Brinton RD
    EBioMedicine; 2015 Dec; 2(12):1888-904. PubMed ID: 26844268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.